| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |